Validation of the self-administered Danish Prostatic Symptom Score system for use in benign prostatic hyperplasia;Validating af det patientadministrerede Danske Prostata Symptom Scoringsskema

Ugeskrift for Laeger

Volumn 159, Issue 5, 1997, Pages 591-597

  Hansen, Bo J ^a   Flyger, Henrik L ^a   Brasso, Klaus ^a   Schou, Jesper ^a   Nordling, Jørgen ^a   Andersen, Jens Thorup ^a   Mortensen, Svend Otto ^a   Meyhoff, Hans Henrik ^a   Walter, Steen ^a   Hald, Tage ^a  

^a NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DENMARK; DRUG SELF ADMINISTRATION; EVALUATION; HUMAN; MALE; PROSTATE HYPERTROPHY; PROSTATECTOMY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE;

DENMARK; EVALUATION STUDIES; HUMANS; MALE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; QUESTIONNAIRES; SELF ADMINISTRATION;

EID: 17144455308     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mebust W, Roizo R, Schroeder F, Villiers A. Correlation between pathology, clinical symptoms and the course of the disease. I: Cockett ATK, Aso Y, Chatelain C, Denis L, Griffiths K, Khoury S, Murphy G, eds. The international consultation on benign prostatic hyperplasia (BPH). Paris: Scientific Communications International, 1991: 53-62.
2. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 1989; 141: 243-8.
3. Boyarsky S, Jones G, Paulson DF, Prout GR Jr. A new look at bladder neck obstruction by food administration regulators: guidelines for the investigation of benign prostatic hyperplasia. Trans Am Assoc Genitourin Surg 1977; 68: 29-32.
4. Madsen PO, Iversen P. A point system for selecting operative candidates. I: Hinman F Jr, ed. Benign prostatic hypertrophy. New York: Springer, 1983: 763-5.
5. Hald T, Nordling J, Andersen JT, Bilde T, Meyhoff HH, Walter S. A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 1991; 138: 59-62.
6. Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chron Dis 1985; 38: 27-36.
7. O'Leary MP, Barry M, Fowler FJ Jr. Hard measures of subjective outcomes: validating symptom indexes in urology. J Urol 1992; 148: 1546-8.
8. Christensen AH, Gjørup T, Hilden J, Fenger C, Henriksen B, Vyberg M. Observer homogeneity in the histological diagnosis of Helicobacter pylori. Latent class analysis, kappa coefficient and repeat frequency. Scand J Gastroenterol 1992; 27: 933-9.
9. Brasso K, Stigsby B, Pilsgaard B, Nordling J. Precision of a patient-weighted symptom score in rostatism. The DAN-PSS-1 questionnaire. Scand J Urol Nephrol 1994; 28: 71-5.
10. Barry M, Fowler FJ Jr, O'Leary MP, Bruskevitz RC, Holtgreve HL, Mebust W. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549-63.
11. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psykometrika 1951; 16: 297-334.
12. Bolognese JA, Kozloff RC, Kunitz SC, Grino PB, Patrick DL, Stoner E. Validation of a symptom questionnaire for benign prostatic hyperplasia. Prostate 1992; 21: 247-54.
13. Flyger H, Holm NR, Nielsen R, Mortensen S. The patient weighted symptom score system DAN- PSS-1 used in the eva-luation of patients before and 2, 4 and 6 months after transurethral prostate resection. Scand J Urol Nephrol 1996; 30: 45-9.
14. Hansen BJ, Nordling J, Mensink HJA Walter S, Meyhoff HH and the ALFECH Study Group. Alfuzosin in the treatment of benign prostatic hyperplasia: effects on symptoms, urinary flow rates and residual volume. A multicentre, double-blind, placebo-controlled trial. Scand J Urol Nephrol suppl 1994; 157: 169-76.
15. Schou J, Poulsen AL, Nordling J. The value of a new symptom score (DAN-PSS) in diagnosing urodynamic infravesical obstruction in BPH. Scand J Urol Nephrol 1994; 27: 489-92.
16. Hanley JA McNeill BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
17. Meyhoff HH, Hald T, Nordling J, Andersen JT, Bilde T, Walter S. A new weighted symptom score system (DAN-PSS-1). Clinical assessment of indications and outcomes of transurethral prostatectomy for uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol 1993; 27: 493-9.
18. Hansen BJ, Flyger H, Mortensen S, Mensink HJA Meyhoff HH and the ALFECH Study Group. Symptomatic outcome of transurethral prostatectomy, alpha-blockade and placebo in the treatment of benign prostatic hyperplasia evaluated with the DAN-PSS-1 score system. Scand J Urol Nephrol 1996; 30: 103-7.
19. Deyo RA, Center RM. Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. J Chron Dis 1986; 39: 897-906.
20. Lepor H, Machi G. Comparison of AUA symptom index on unselected males and females between fifty-five and seventy-nine years of age. Urology 1993; 42: 36-41.